Traded Mar 4 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Jan 8, 2026 · Filed Feb 14, 2026
Not classified as an open-market trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
other
Code J — not an open-market trade
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded Mar 4 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
William Guyer (Chief Development Officer) sold ~$296K of Corcept Therapeutics
Scheduled in advanceTraded Mar 4 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.